AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ACTINOGEN MEDICAL LTD

0.043

-0.001-2.27%

Volume:3.74M

Turnover:162.37K

Market Cap:136.86M

PE:-8.70

High:0.045

Open:0.045

Low:0.042

Close:0.044

52wk High:0.072

52wk Low:0.019

Shares:3.18B

Float Shares:2.61B

Volume Ratio:0.44

T/O Rate:0.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.005

EPS(LYR):-0.005

ROE:-77.47%

ROA:-41.91%

PB:7.46

PE(LYR):-8.70

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.74%

Capital Flow

Inflow:

Outflow:

News

Actinogen Medical Receives Green Light to Continue Pivotal XanaMIA Alzheimer’s Trial

Actinogen Medical to Raise AU$12 Million via Share Placement

MT Newswires Live

BRIEF-Actinogen Medical To Raise A$12.0 Million

Actinogen Medical Ltd - to Raise a$12.0 Mln at a$0.042 per Share

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ACW.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ACW.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","market":"AU","secType":"STK","nameCN":"ACTINOGEN MEDICAL LTD","latestPrice":0.043,"timestamp":1770700320000,"preClose":0.044,"halted":0,"volume":3737857,"delay":0,"changeRate":-0.02272727272727275,"nameEN":"ACTINOGEN MEDICAL LTD","floatShares":2607880613,"shares":3182678236,"eps":-0.004944,"marketStatus":"Not Yet Opened","change":-0.001,"latestTime":"02-10 16:12:00 AEDT","open":0.045,"high":0.045,"low":0.042,"amount":162367,"amplitude":0.068182,"askPrice":0.044,"askSize":735689,"bidPrice":0.043,"bidSize":127062,"shortable":3,"etf":0,"ttmEps":-0.004944,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.044,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.439046,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ACW.AU\",,,,,undefined,":{"symbol":"ACW.AU","floatShares":2607880613,"roa":"-41.91%","roe":"-77.47%","lyrEps":-0.004944,"volumeRatio":0.439046,"shares":3182678236,"dividePrice":0,"high":0.045,"amplitude":0.068182,"preClose":0.044,"low":0.042,"week52Low":0.019,"pbRate":"7.46","psRate":"24.93","week52High":0.072,"institutionHeld":0,"latestPrice":0.043,"committee":-0.705449,"eps":-0.004944,"divideRate":0,"volume":3737857,"delay":0,"ttmEps":-0.004944,"open":0.045,"prevYearClose":0.061,"prevWeekClose":0.043,"prevMonthClose":0.045,"prevQuarterClose":0.061,"fiveDayClose":0.045,"twentyDayClose":0.057,"sixtyDayClose":0.047,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ACW.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-10-19","symbol":"ACW.AU","defaultRemindTime":1603062000000,"type":"split","dateTimestamp":1603026000000,"forFactor":98,"toFactor":100,"ratio":0.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ACW.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ACW.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608618528","title":"Actinogen Medical Receives Green Light to Continue Pivotal XanaMIA Alzheimer’s Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2608618528","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608618528?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:00","pubTimestamp":1770037244,"startTime":"0","endTime":"0","summary":"Actinogen Medical Ltd. has announced that its independent Data Monitoring Committee has recommended the continuation of the XanaMIA pivotal Alzheimer's disease trial following a positive interim analysis of unblinded safety and efficacy data. The trial is fully enrolled, and topline final results are expected to be reported in November 2026. Following the completion of the trial, results will be presented at a key Alzheimer's disease scientific meeting and published in a peer-reviewed journal. All participants in the XanaMIA trial are eligible for an open-label extension phase, during which they will receive Xanamem 10 mg for up to 25 months. Additionally, a second and larger global pivotal trial is planned to commence in 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDLb1HFgw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","IE00B64PRP62.GBP","SG9999014013.SGD","BK7508","SG9999014021.USD","SG9999014039.USD","BK4585","BK7067","LU2210149790.SGD","ACW.AU","BK4112","IE00BGHQF748.EUR","SG9999014005.SGD","BK4588","IE00BKPKM429.USD","NDAQ"],"gpt_icon":0},{"id":"2608835297","title":"Actinogen Medical to Raise AU$12 Million via Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2608835297","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608835297?lang=en_us&edition=fundamental","pubTime":"2026-02-02 10:32","pubTimestamp":1769999544,"startTime":"0","endTime":"0","summary":"Actinogen Medical (ASX:ACW) received firm commitments to raise about AU$12 million through the issue of 285.7 million shares at AU$0.042 apiece, according to a Monday filing with the Australian bourse","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","ACW.AU","BK7508"],"gpt_icon":0},{"id":"2608583394","title":"BRIEF-Actinogen Medical To Raise A$12.0 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2608583394","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608583394?lang=en_us&edition=fundamental","pubTime":"2026-02-02 09:53","pubTimestamp":1769997235,"startTime":"0","endTime":"0","summary":"BRIEF-Actinogen Medical To Raise A$12.0 MillionFeb 2 (Reuters) - Actinogen Medical Ltd ACW.AX:TO RAISE A$12.0 MILLION AT A$0.042 PER SHAREFurther company coverage: ACW.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YV1T5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ACW.AU","BK7508"],"gpt_icon":0},{"id":"2608882347","title":"Actinogen Medical Ltd -  to Raise a$12.0 Mln at a$0.042 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2608882347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608882347?lang=en_us&edition=fundamental","pubTime":"2026-02-02 06:57","pubTimestamp":1769986666,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260201:nFWN3YV1T5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","ACW.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":27,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ACW.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.017447}]}}